September 21, 2014 4:45 AM ET

Pharmaceuticals

Company Overview of Catalent Pharma Solutions, Inc.

Executive Profile

John R. Chiminski

Chief Executive Officer, President and Director, Catalent, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 9 different industries.

See Board Relationships
50$2,466,420
As of Fiscal Year 2014

Background

Mr. John R. Chiminski has been the Chief Executive Officer and President of Catalent, Inc. (formerly, PTS Holdings Corp.) since March 2009. Mr. Chiminski has been the Chief Executive Officer and President at Catalent Pharma Solutions, Inc. since March 17, 2009. He serves as the Chief Executive Officer and President of Catalent Pharma Solutions, LLC. He served a variety of senior management positions at GE Healthcare. He served as the Chief Executive Officer and President ...

Corporate Headquarters

14 Schoolhouse Road
Somerset, New Jersey 08873

United States

Phone: 732-537-6200
Fax: 732-537-6480

Board Members Memberships

Director
Director
Chief Executive Officer, President and Director
2009-Present
Chief Executive Officer, President and Director
2009-Present
Director
2012-Present
Director
2012-Present
Director

Education

MBA 1996
Northwestern University
MS
Purdue University
Unknown/Other Education 1986
Michigan State University
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations

Annual Compensation

Salary$850,000
Total Annual Compensation$850,000

Stocks Options

All Other Compensation$36,420
Exercisable Options$668,500
Exercisable Options Value$5,984,615
Total Value of Options$10,504,550
Total Number of Options$1,645,000

Total Compensation

Total Annual Cash Compensation$2,466,420
Total Short Term Compensation$850,000
Other Long Term Compensation$36,420
Total Calculated Compensation$2,466,420
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Walter M. Rosebrough Jr.Chief Executive Officer, President, Director and Member of Compliance Committee
Steris Corp.
$788.5K
Joseph L. Herring Chairman and Chief Executive Officer
Covance Inc.
$1.0M
F. Michael Ball Chief Executive Officer, Director and Member of Science, Technology & Quality Committee
Hospira Inc.
$1.0M
Kieran T. Gallahue Chairman and Chief Executive Officer
CareFusion Corporation
$1.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Catalent Pharma Solutions, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.